Merck and Premier Inc. Collaborating to Help Reduce Clostridium Difficile (C. Diff) Infection
May 31, 2018
May 31, 2018
CHARLOTTE, North Carolina, May 31 -- Premier, a healthcare improvement company, issued the following news release:
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, have expanded their preventative and chronic disease care collaboration to include a new effort designed to help reduce the recurrence of Clostridium difficile infection (C. diff).
Merck and Premier(R) will develop . . .
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, have expanded their preventative and chronic disease care collaboration to include a new effort designed to help reduce the recurrence of Clostridium difficile infection (C. diff).
Merck and Premier(R) will develop . . .